Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis

医学 拉米夫定 乙型肝炎免疫球蛋白 齐多夫定 乙型肝炎 乙型肝炎病毒 免疫学 养生 双腺苷 丙型肝炎 丙型肝炎病毒 正庚病毒 病毒学 利巴韦林 传输(电信) 暴露后预防 接种疫苗 七鳃鳗科 内科学 病毒性疾病 病毒 人类免疫缺陷病毒(HIV) 工程类 电气工程
出处
期刊:PsycEXTRA Dataset 被引量:366
标识
DOI:10.1037/e548242006-001
摘要

This report updates and consolidates all previous U.S. Public Health Service recommendations for the management of health-care personnel (HCP) who have occupational exposure to blood and other body fluids that might contain hepatitis B virus (HBV), hepatitis C virus (HCV), or human immunodeficiency virus (HIV). Recommendations for HBV postexposure management include initiation of the hepatitis B vaccine series to any susceptible, unvaccinated person who sustains an occupational blood or body fluid exposure. Postexposure prophylaxis (PEP) with hepatitis B immune globulin (HBIG) and/or hepatitis B vaccine series should be considered for occupational exposures after evaluation of the hepatitis B surface antigen status of the source and the vaccination and vaccine-response status of the exposed person. Guidance is provided to clinicians and exposed HCP for selecting the appropriate HBV PEP. Immune globulin and antiviral agents (e.g., interferon with or without ribavirin) are not recommended for PEP of hepatitis C. For HCV postexposure management, the HCV status of the source and the exposed person should be determined, and for HCP exposed to an HCV positive source, follow-up HCV testing should be performed to determine if infection develops. Recommendations for HIV PEP include a basic 4-week regimen of two drugs (zidovudine [ZDV] and lamivudine [3TC]; 3TC and stavudine [d4T]; or didanosine [ddI] and d4T) for most HIV exposures and an expanded regimen that includes the addition of a third drug for HIV exposures that pose an increased risk for transmission. When the source person's virus is known or suspected to be resistant to one or more of the drugs considered for the PEP regimen, the selection of drugs to which the source person's virus is unlikely to be resistant is recommended. In addition, this report outlines several special circumstances (e.g., delayed exposure report, unknown source person, pregnancy in the exposed person, resistance of the source virus to antiretroviral agents, or toxicity of the PEP regimen) when consultation with local experts and/or the National Clinicians' Post-Exposure Prophylaxis Hotline ([PEPline] 1-888-448-4911) is advised. Occupational exposures should be considered urgent medical concerns to ensure timely postexposure management and administration of HBIG, hepatitis B vaccine, and/or HIV PEP.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
一一一完成签到,获得积分10
刚刚
黑色的白鲸完成签到,获得积分10
刚刚
Prat_2000完成签到 ,获得积分10
刚刚
韩邹光完成签到,获得积分10
2秒前
林牧完成签到,获得积分10
2秒前
3秒前
Akim的应助被可妍昇采纳,获得10
3秒前
蔡博颖完成签到,获得积分10
4秒前
4秒前
Julian的应助被ZZ采纳,获得30
5秒前
Lucas的应助被山复尔尔采纳,获得10
5秒前
5秒前
搜集达人的应助被wangsiheng采纳,获得10
7秒前
嘻嘻哈哈的应助被小红采纳,获得10
7秒前
Echo完成签到 ,获得积分10
8秒前
9秒前
10秒前
mlxgxxx发布了新的文献求助10
11秒前
ket的应助被发SCI超人采纳,获得10
11秒前
13515完成签到 ,获得积分10
11秒前
科研通AI6.3的应助被发SCI超人采纳,获得10
11秒前
12秒前
852的应助被zxcv采纳,获得10
15秒前
15秒前
15秒前
lulu发布了新的文献求助10
16秒前
i3i完成签到 ,获得积分10
16秒前
16秒前
英吉利25发布了新的文献求助10
19秒前
19秒前
21秒前
wanci的应助被山复尔尔采纳,获得10
21秒前
拔土豆的草完成签到,获得积分10
21秒前
慕青的应助被lulu采纳,获得150
21秒前
落酒完成签到 ,获得积分10
22秒前
23秒前
隐形曼青的应助被Elsevier大王采纳,获得10
24秒前
24秒前
Nole的应助被Elsevier大王采纳,获得30
24秒前
Nole的应助被Elsevier大王采纳,获得10
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187149
求助须知:如何正确求助?哪些是违规求助? 9575342
关于积分的说明 21840758
捐赠科研通 7784858
什么是DOI,文献DOI怎么找? 3434935
关于科研通互助平台的介绍 2559340
邀请新用户注册赠送积分活动 2481777